Clinical Trial Update: A Prospective Phase II Dose Escalation Study Using IMRT for High Risk N0 M0 Prostate Cancer. ICORG 08-17 [Phase 2]

View source ↗

Summary

This entry describes an ongoing Phase II dose-escalation trial using intensity-modulated radiotherapy (IMRT) for high-risk non-metastatic prostate cancer (ICORG…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: Cancer Trials Ireland | Conditions: Prostate Cancer | Phase 2 | Status: ACTIVE_NOT_RECRUITING